Deep brain stimulation (DBS) is a well‐defined treatment for motor symptoms in advanced PD. Although several studies have investigated the DBS effect on non‐motor symptoms (NMS), controversial results exist regarding this matter. The aim of this meta‐analysis and systematic review was to assess the bilateral subthalamic nucleus (STN) DBS effect on NMS of PD. We conducted a systematic search on the literature of Web of Science (WOS), PubMed/MEDLINE, Scopus, Cochrane, and Embase. An additional hand search was also done. Finally, a meta‐analysis was conducted on 10 studies containing pre‐ and post‐bilateral STN‐DBS data regarding NMS acquired using Non‐Motor Symptoms Scale for Parkinson's Disease (NMSS) or Non‐Motor Symptoms Questionnaire (NMSQ). A random‐effects model was used to determine weighted mean differences, and the heterogeneity index was evaluated using Cochrane's Q test. Our study results indicated that bilateral STN‐DBS significantly reduced total NMSS and NMSQ score (WMD −17.73; 95% confidence interval [CI] −20.28 to −15.18, WMD −2.19; 95% CI −2.98 to −1.40), respectively, and no publication bias was found. Regarding each of the NMSS domains, DBS significantly reduced the scores of following domains: sleep (WMD ‐5.98; 95% CI ‐6.82 to −5.15), miscellaneous (WMD −4.19; 95% CI −4.96 to −3.43), urinary (WMD −2.99; 95% CI −3.78 to −2.19), sexual (WMD −0.65; 95% CI −1.16 to −0.14), and attention/memory (WMD −0.59; 95% CI −1.15 to −0.03). This meta‐analysis demonstrated that bilateral STN‐DBS has beneficial effects on NMS of PD.